Gamida Cell   Report issue

For profit Phase 2 Phase 3
Founded: Jerusalem Israel (1998)

Organization Overview

First Clinical Trial
2007
NCT00444262
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

GAMIDA | Gamida Cell ltd